MYC and hepatocellular carcinoma: Collectively, we have developed a novel organic selenium compound, CU27, which can bind c‐Myc bHLH/LZ domains, block c‐Myc‐Max complex formation, and prevent its occupancy on target gene promoters in HCC cells.